Antibiotic resistance is a serious threat to public health. When antibiotics don't work, we risk not being able to treat many types of infections and people who would previously have been cured, can ...

The World Health Organization estimates that about 9 million people become ill from the life-threatening infection and ...

Could that “just-in-case” antibiotic be doing more harm than good to your child’s long-term health? New research links early ...

Whether you are placing a central line, managing a Clostridioides difficile case, or keeping a surgical field sterile, you're ...

SARPLLM leverages large language modeling and quantum algorithms to predict Salmonella AMR, offering robust analysis and user ...

Alaska is seeing a dangerous gonorrhea outbreak, while the CDC's STD lab and field staff have been cut. What happens to ...

A newly approved antibiotic to treat urinary tract infections, gepotidacin, also may help fight drug-resistant gonorrhea, a ...

A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial, according to ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea. It could be the first new type of ...

The WHO Bacterial Priority Pathogens List (WHO BPPL) is instrumental in guiding research and development (R&D), investments, and global policy towards tackling the most urgent antibiotic-resistant ...

This Research Topic highlights the alarming potential impact of antimicrobial resistance, which is projected to cause 10 million deaths annually by 2050.